Unexpected flashes of light in your eye can be alarming, and in many cases, it's something that should be discussed with your ...

Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire monofocal and toric ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

In-office suprachoroidal viscopexy may be a feasible approach for repairing rhegmatogenous retinal detachment.

Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...

Most efforts were directed at pharmacological agents, which modify the molecular structure of the vitreous and its attachment to the retina, which has been called 'pharmacological vitreolysis'.

4 Department of Radiology, Addenbrooke’s NHS Trust, Cambridge, UK 5 Department of Audiology, Addenbrooke’s NHS Trust, Cambridge, UK Correspondence to: M P Snead Vitreoretinal Service, Box 41, ...

Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice ...

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 pivotal trial, according to a press release from Tenpoint Therapeutics.

Retinal detachments are painless, but there are other signs that may tell you something isn't right. If left untreated, this condition could lead to blindness. Here are three surprising symptoms to be ...